GTG 7.35% 6.3¢ genetic technologies limited

Ann: Financing and Restructure Plan Finalised, page-2

  1. 656 Posts.
    lightbulb Created with Sketch. 13
    Focus now on two key areas, Brevagen Plus and Patent Infrigement. New management, cost cutting and a launch in October sets the scene for a new beginning. Ironbridge last loan funds to convert at market less 40% so lets give them something to think about! Once they are out of the way, Brevagen sales and 7 figure Cash settlements for patent breeches will pave the way!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.